Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Show more
-- Navenibart (STAR-0215), the Potential Market-Leading Therapy for the Treatment of Hereditary Angioedema, on Track for Expected Phase 3 Initiation in Q1 2025 -- -- Final 3- and 6-Month Results...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 210,000...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.52 | -5.11307767945 | 10.17 | 10.17 | 8.61 | 332944 | 9.47930632 | CS |
| 4 | -2.05 | -17.5213675214 | 11.7 | 12.515 | 8.61 | 239437 | 10.76250865 | CS |
| 12 | -2.46 | -20.313790256 | 12.11 | 12.92 | 8.61 | 322716 | 11.35536231 | CS |
| 26 | 0.39 | 4.21166306695 | 9.26 | 12.92 | 8.585 | 362698 | 10.60709095 | CS |
| 52 | 5.04 | 109.327548807 | 4.61 | 16.9 | 4.41 | 608319 | 11.12573458 | CS |
| 156 | 2.85 | 41.9117647059 | 6.8 | 16.9 | 2.36 | 304923 | 10.48187565 | CS |
| 260 | 1.12 | 13.1301289566 | 8.53 | 16.9 | 2.36 | 289648 | 10.44648087 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
